FDA

US FDA Grants Breakthrough Device Status To ErlySign’s Saliva-Based Oral Cancer Test

US FDA Grants Breakthrough Device Status To ErlySign’s Saliva-Based Oral Cancer Test

13 Feb 2026

1 min read

FDA Approves Keytruda & Keytruda QLEX With Paclitaxel ± Bevacizumab For PD‑L1+ Platinum‑Resistant Ovarian Cancer

Precision Medicine

FDA Approves Keytruda & Keytruda QLEX With Paclitaxel ± Bevacizumab For PD‑L1+ Platinum‑Resistant Ovarian Cancer

13 Feb 2026

2 min read

USFDA Approves Alembic’s Generic Parkinson’s Disease Treatment Tablets

USFDA Approves Alembic’s Generic Parkinson’s Disease Treatment Tablets

09 Feb 2026

1 min read

Read More

Voice Of HealthCare

vohnetwork.com